Bay Colony Advisory Group, Inc D Astrazeneca PLC Transaction History
Bay Colony Advisory Group, Inc D
- $580 Million
- Q2 2024
A detailed history of Bay Colony Advisory Group, Inc D transactions in Astrazeneca PLC stock. As of the latest transaction made, Bay Colony Advisory Group, Inc D holds 20,881 shares of AZN stock, worth $1.66 Million. This represents 0.28% of its overall portfolio holdings.
Number of Shares
20,881
Previous 19,435
7.44%
Holding current value
$1.66 Million
Previous $1.32 Million
23.71%
% of portfolio
0.28%
Previous 0.24%
Shares
10 transactions
Others Institutions Holding AZN
# of Institutions
1,274Shares Held
483MCall Options Held
5.99MPut Options Held
5.22M-
Price T Rowe Associates Inc Baltimore, MD61.3MShares$4.88 Billion0.51% of portfolio
-
Wellington Management Group LLP Boston, MA49.1MShares$3.92 Billion0.6% of portfolio
-
Primecap Management CO Pasadena, CA42.9MShares$3.42 Billion2.21% of portfolio
-
Capital International Investors Los Angeles, CA34.5MShares$2.75 Billion0.48% of portfolio
-
Jennison Associates LLC17.3MShares$1.38 Billion0.79% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $247B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...